Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Smith & Nephew PLC

Dr. Deepak S. Nath Ph.D.

CEO & Director

Mr. John Terence Rogers

CFO & Executive Director

Mr. Paul  Connolly

President of Global Operations

Mr. Andrew  Swift

Vice President of Investor Relations

Ms. Helen  Barraclough

Group General Counsel & Company Secretary

Ms. Alison  Parkes

Chief Compliance Officer & Compliance APAC

Mr. Joe  Metzger

Senior Vice President of Marketing Services & Communications

Mr. Philip G. Cowdy

Chief Corporate Development & Corporate Affairs Officer

Ms. Elga  Lohler

Chief Human Resources Officer

Dr. Vasant  Padmanabhan Ph.D.

President of Research & Development and Ear, Nose & Throat

Smith & Nephew PLC (SN) Stock Analysis, Discussion Forum and Financial Metrics - LSE Exchange

SN's latest dividend is 0.144 GBP on October 3, 2024

SN Stock Discussion Forum and Message Board

News for LSE: SN